Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-20-000779

← back to feed
Filed
Aug 19, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jun 30, 2020 5.88M sh
Short Term Investments Q2 2020 · Jun 30, 2020 $45.49K
Short Term Investments Q2 2020 · Dec 31, 2019 $41.69K
Current Liabilities Q2 2020 · Jun 30, 2020 $180.93K
Current Liabilities Q2 2020 · Dec 31, 2019 $19.42K
Total Liabilities Q2 2020 · Jun 30, 2020 $1.36M
Total Liabilities Q2 2020 · Dec 31, 2019 $1.01M
Current Assets Q2 2020 · Jun 30, 2020 $66.21K
Current Assets Q2 2020 · Dec 31, 2019 $118.16K
Total Assets Q2 2020 · Jun 30, 2020 $4.17M
Total Assets Q2 2020 · Dec 31, 2019 $4.24M
Net Income Q2 2020 · Mar 31, 2020 −$241.82K
Net Income Q2 2020 · Jun 30, 2019 −$181.75K
Net Income Q2 2020 · Jun 30, 2019 −$382.14K
Net Income Q2 2020 · Mar 31, 2019 −$200.4K
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$326.44K
Cash And Equivalents Q2 2020 · Jun 30, 2019 $344.98K
Cash And Equivalents Q2 2020 · Dec 31, 2018 $131.41K
Stockholders Equity Q2 2020 · Jun 30, 2019 $43.29K
Stockholders Equity Q2 2020 · Mar 31, 2019 $220.47K
Stockholders Equity Q2 2020 · Dec 31, 2018 $403.59K
Sga Expense Q2 2020 · Jun 30, 2019 $66.36K
Sga Expense Q2 2020 · Jun 30, 2019 $124.61K
Rd Expense Q2 2020 · Jun 30, 2019 $113.66K
Rd Expense Q2 2020 · Jun 30, 2019 $245.34K
Operating Income Q2 2020 · Jun 30, 2019 −$171.33K
Operating Income Q2 2020 · Jun 30, 2019 −$383.68K
Revenue Q2 2020 · Jun 30, 2019 $50.75K
Revenue Q2 2020 · Jun 30, 2019 $83.12K